Join
Live feed
·
PRReleasevia Quantisnow
Synaptogenix Inc. logo

Synaptogenix Discloses Positive Results of Further Bryostatin Trial Analyses in Presentation at Alzheimer's Association International Conference 2021

ByQuantisnow·Wall Street's wire, on your screen.
SNPX· Synaptogenix Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SNPX (Synaptogenix Inc.) and more on Quantisnow.